Medicilon

Medicilon is a professional pharmaceutical preclinical integrated R&D service contract research organization (CRO), providing a full range of one-stop new drug R&D services. Our services cover the entire process of preclinical new drug research, including drug discovery, pharmacology research and preclinical research. Our drug discovery services include chemical synthesis, compound activity screening and optimization, structural biology research, protein target validation, etc.; Pharmacological researches include process research of API and formulation, quality standards and stability research, etc.; Preclinical researches include pharmacodynamics, pharmacokinetics, toxicological safety evaluation, etc.

Drug discovery is the initial stage of drug research and development. Through early research, the genetic functions and targets of target diseases are selected and confirmed, the lead compounds are screened and optimized, and the druggability studies such as early safety screening and drug modification are carried out to obtain druggability candidate compounds. Medicilon’s drug discovery service is divided into two departments: Chemistry and Biology, with chemical and biological laboratories, equipped with SFC, Biacore 8K, microplate reader, LC-MS, HPLC and other instruments, including protein purification labs, cell culture labs, protein crystal labs and drug discovery and screening platforms.